Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 19

Results For "2022"

1412 News Found

Dr. Jitendra Singh launches multi-disciplinary post-doctoral courses in Bio-Sciences
News | February 06, 2024

Dr. Jitendra Singh launches multi-disciplinary post-doctoral courses in Bio-Sciences

1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector


Unichem Laboratories posts Q3 FY24 consolidated PAT at Rs. 83.99 Cr
News | February 06, 2024

Unichem Laboratories posts Q3 FY24 consolidated PAT at Rs. 83.99 Cr

Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023


Sun Pharma Advanced Research Company Q3 FY24 loss at Rs. 99.65 Cr
News | February 06, 2024

Sun Pharma Advanced Research Company Q3 FY24 loss at Rs. 99.65 Cr

Sun Pharma Advanced Research Company has reported total income of Rs. 20.25 crores during the period ended December 31, 2023


RPG Life Sciences posts Q3 FY24 PAT at Rs. 26.46 Cr
News | February 05, 2024

RPG Life Sciences posts Q3 FY24 PAT at Rs. 26.46 Cr

RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023


TTK Healthcare posts Q3 FY24 PAT at Rs. 12.89 Cr
News | February 05, 2024

TTK Healthcare posts Q3 FY24 PAT at Rs. 12.89 Cr

TTK Healthcare has reported total income of Rs. 199.75 crores during the period ended December 31, 2023


KIMS posts Q3 FY24 consolidated PAT at Rs. 71.84 Cr
News | February 05, 2024

KIMS posts Q3 FY24 consolidated PAT at Rs. 71.84 Cr

KIMS has reported total income of Rs. 609.091 crores during the period ended December 31, 2023


DPIIT recognises 1, 17,254 startups as on Dec 2023
Startup | February 03, 2024

DPIIT recognises 1, 17,254 startups as on Dec 2023

At least one recognised startup in every State and UT; spread across over 80% of districts


Abbott India posts Q3 FY24 PAT at Rs. 310.98 Cr
News | February 03, 2024

Abbott India posts Q3 FY24 PAT at Rs. 310.98 Cr

Abbott India has reported total income of Rs. 1492.75 crores during the period ended December 31, 2023


Thyrocare Technologies posts Q3 FY24 consolidated PAT at Rs. 15.35 Cr
News | February 03, 2024

Thyrocare Technologies posts Q3 FY24 consolidated PAT at Rs. 15.35 Cr

Thyrocare Technologies has reported total income of Rs. 137.47 crores during the period ended December 31, 2023


Dr Lal Path Labs posts Q3 FY24 consolidated PAT at Rs. 81.3 Cr
News | February 03, 2024

Dr Lal Path Labs posts Q3 FY24 consolidated PAT at Rs. 81.3 Cr

Dr. Lal Path Labs has reported total income of Rs. 557.2 crores during the period ended December 31, 2023